A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Participants
Clinical trial NCT05894928 · COMPLETED
Trial details
- NCT number
- NCT05894928
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-07
- Primary completion
- 2023-07-09
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.